News Conference News VIVA 2024 Advocates Urge Heat Maps and Grassroots Campaigns to Improve PAD Care L.A. McKeown November 07, 2024
News Conference News VIVA 2024 Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II L.A. McKeown November 06, 2024
News Conference News VIVA 2023 ‘Dire’ Lack of Vascular Care in Underserved Areas Needs Creativity, Compassion L.A. McKeown November 03, 2023
News Conference News VIVA 2022 ‘Heartless’ Indifference Drives PAD/CLTI Amputations in Underserved Groups L.A. McKeown November 04, 2022
News Conference News VIVA 2022 TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years L.A. McKeown November 03, 2022
News Conference News VIVA 2021 Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI L.A. McKeown October 08, 2021
News Conference News VIVA 2021 Striking Racial Gaps Exist in Care for Peripheral Interventions, Registry Affirms L.A. McKeown October 07, 2021
News Conference News VIVA 2021 Vascular Care Falls Short Before Amputation for CLI: Medicare Analysis L.A. McKeown October 06, 2021
News Conference News VIVA 2019 Hope for Bioresorbable Vascular Scaffolds in Peripheral Disease Below the Knee? L.A. McKeown November 06, 2019
News Conference News VIVA 2018 LUTONIX BTK: Hope for Challenging Patients at High Risk for Amputation L.A. McKeown November 07, 2018
News Conference News VIVA 2017 DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease L.A. McKeown September 13, 2017
News Conference News VIVA 2016 Bioresorbable Scaffold Shows Sustained Promise in Superficial Femoral and Iliac Artery Lesions L.A. McKeown September 22, 2016
News Conference News VIVA 2016 Positive Results Continue at 2 Years for Paclitaxel-Eluting PAD Stent L.A. McKeown September 20, 2016